PTIX - Protagenic Therapeutics, Inc.\new
0.74
-0.560 -75.676%
Share volume: 1,922,073
Last Updated: 01-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$1.30
-0.56
-0.43%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2026 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-13-2025 | 11-26-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||
| Operating expenses | 1.738 M | 1.667 M | 652.066 K | 1.448 M | 506.387 K | |
| Selling general and admin | 277.613 K | 453.298 K | 287.882 K | 567.736 K | 233.158 K | |
| Research and development | 1.461 M | 1.214 M | 364.184 K | 880.372 K | 273.229 K | |
| Total expenses | 1.738 M | 1.667 M | 652.066 K | 1.448 M | 1.114 M | |
| -4.09% | -60.89% | 122.08% | -23.08% | |||
| Operating income | -1.738 M | -1.667 M | -652.066 K | -1.448 M | -1.114 M | |
| Ebit | -1.738 M | -1.616 M | -652.066 K | -1.448 M | -903.833 K | |
| Pretax income | -1.724 M | -1.607 M | -640.785 K | -1.440 M | -869.496 K | |
| -6.83% | -60.11% | 124.73% | -39.62% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.724 M | -1.607 M | -640.785 K | -1.440 M | -869.496 K | |
| 6.83% | 60.11% | -124.73% | 39.62% |